Skip to main content

Advertisement

Log in

Prognostic importance of home blood pressure measurement in patients with diabetic nephropathy

  • Original article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Aims

Controlling hypertension has been revealed to be as important as controlling hyperglycemia to prevent the progression of diabetic nephropathy. Home blood pressure (HBP) measurement is useful for the treatment of hypertension. This study aimed to determine whether HBP measurement is a stronger predictor of the progression of diabetic nephropathy than clinic blood pressure (CBP) measurement.

Method

A multicenter follow-up study was performed at the Japan National Hospital Organization. A database of type 2 diabetic patients was constructed. In addition to CBP measurement patients, those using HBP were included in the database. Fifty-four patients with diabetic nephropathy were extracted from the database and analyzed. The rate of decline of the estimated glomerular filtration rate (eGFR) was calculated as the outcome. Correlations between the rate of eGFR decline and various clinical and laboratory parameters, including HBP and CBP measurement, were analyzed.

Results

The white-coat effect and reverse white-coat effect were frequently observed. The rate of eGFR decline correlated significantly with home systolic blood pressure (HSBP) measurement, but not with clinic systolic blood pressure (CSBP) measurement. Stepwise multiple linear regression analysis was performed. The rate of eGFR decline was significantly explained by the morning HSBP reading. The rate of eGFR decline was also significantly explained by the average of the morning HSBP readings during the follow-up period, the eGFR and age at baseline in the model, which included CBP and HBP measurements during the follow-up period instead of those at baseline.

Conclusion

Home blood pressure measurement is useful for predicting the prognosis of diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–32.

    Article  PubMed  Google Scholar 

  2. Idem. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;317:703–13.

  3. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;Suppl 1:S12–54.

    Article  Google Scholar 

  4. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.

    CAS  PubMed  Google Scholar 

  5. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001;60:277–83.

    Article  CAS  PubMed  Google Scholar 

  6. Rossing K, Christensen PK, Hovind P, Parving HH. Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia. 2005;48:2241–7.

    Article  CAS  PubMed  Google Scholar 

  7. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348:2285–93.

    Article  CAS  PubMed  Google Scholar 

  8. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–7.

    Article  CAS  PubMed  Google Scholar 

  9. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.

    Article  PubMed  Google Scholar 

  10. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329:145.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.

    Article  CAS  PubMed  Google Scholar 

  12. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.

    Article  CAS  PubMed  Google Scholar 

  13. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–11.

    Article  CAS  PubMed  Google Scholar 

  14. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007;50:927–37.

    Article  PubMed  Google Scholar 

  15. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994–1001.

    Article  PubMed  Google Scholar 

  16. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;3:656–64.

    Article  Google Scholar 

  17. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4:20–6.

    Article  CAS  PubMed  Google Scholar 

  18. Lantelme P, Milon H, Gharib C, Gayet C, Fortrat JO. White coat effect and reactivity to stress: cardiovascular and autonomic nervous system responses. Hypertension. 1998;31:1021–9.

    Article  CAS  PubMed  Google Scholar 

  19. Brenner BM, Cooper ME, de Zeeuw D, RENAAL Study Investigators et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–9.

    Article  CAS  PubMed  Google Scholar 

  20. Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G. The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol. 1998;9:2336–43.

    CAS  PubMed  Google Scholar 

  21. Weiner DE, Tighiouart H, Levey AS, Elsayed E, Griffith JL, Salem DN, Sarnak MJ. Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol. 2007;18:960–6.

    Article  PubMed  Google Scholar 

  22. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007;50:908–17.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was executed as Research in the Policy-Based Medical Services Network for Kidney Diseases of the Japan Hospital Organization and supported by the Japan National Hospital Organization collaborative clinical research grant. We want to thank Ms. T. Takano and Ms. A. Nakayama for their valuable assistance. We also want to thank the following investigators who participated in this study: A. Soyama, N. Seki, Y. Horita, A. Hurusu, H. Seino, H. Noto, Y. Tominaga and T. Sugawara.

Conflict of interest

Nothing to declare.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to M. Nishimura.

Additional information

Authors except for Hoshiyama Y are members of the Japan National Hospital Organization (NHO) group.

About this article

Cite this article

Nishimura, M., Kato, M., Shimada, F. et al. Prognostic importance of home blood pressure measurement in patients with diabetic nephropathy. Diabetol Int 2, 10–18 (2011). https://doi.org/10.1007/s13340-011-0018-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-011-0018-y

Keywords

Navigation